iMDx posts Q2 loss as FDA review of GraftAssureDx continues

Go back to iMDx posts Q2 loss as FDA review of GraftAssureDx continues
BIO-RAD LABORATORIES (NYSE: BIO) Delayed: 380.96 --0 (-0%)
Previous Close $380.96    52 Week High $174.02 
Open $380.96    52 Week Low $122.03 
Day High $380.96    P/E 123.29 
Day Low $380.96    EPS $3.09 
Volume 934       

(NASDAQ: IMDX) Delayed: 3.84 --0 (-0%)
Previous Close $3.84    52 Week High
Open $3.84    52 Week Low
Day High $3.84    P/E N/A 
Day Low $3.84    EPS
Volume 894